Breast cancer

Updated 09 November 2017

Protein suppresses tumour growth

Researchers have discovered a protein which can reduce the malignancy of breast cancer tumours and also predict whether the cancer will metastasise, according to a new study.

0
Researchers have discovered a protein which can reduce the malignancy of breast cancer tumours and also predict whether the cancer will metastasise, according to a new study.

"This protein seems to be suppressing tumour growth," said study author Kent Hunter of the National Cancer Institute outside of Washington. In studies on mice and in gene expression profiles of human cancer cells, Hunter and his team found that they could dramatically slow the growth of breast cancer tumours and prevent the cancer from spreading.

They did this by inserting extra copies of the gene that expresses the protein into the tumour, according to the study published in the Proceedings of the National Academy of Sciences.

While those tumours were not eliminated, they grew to one tenth of the size of those which had not been stimulated to overproduce the protein. They also had molecular profiles of significantly less malignant tumours and did not spread.

What the finding means
"What we're interested in is looking at how this would be induced by other means... to find a drug that would turn this gene on in tumours," Hunter said. "That would reduce the malignancy of the tumour and prolong survival."

In the meantime, the presence, or lack thereof, of this protein could be used to predict which patients are at risk of metastasis, he said.

"We could hopefully spare those patients who will not benefit the rigors associated with adjuvant therapy," he explained.

While there are at least two gene expression profiles currently in clinical trials to test the risk of metastasis, researchers have not yet teased out the root cause of those gene expressions.

"We know what the root cause of this gene expression change: that is this protein," Hunter said. "That gives us a handle on how we can investigate what is causing all these particular gene expression signatures and allows us potentially to do molecular targeting down the line that might somehow affect the cancer."

Any type of clinical application is still far away, he cautioned. – (Sapa)

April 2008

Read more:
Protein, skin cancer link
Master breast cancer gene found

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Breast cancer expert

Dr Gudgeon qualified in Birmingham, England, in 1968. She has more than 40 years experience in oncology, and in 1994 she founded her practice, Cape Breast Care, where she treats benign and malignant breast cancers. Dr Boeddinghaus obtained her qualification at UCT Medical School in 1994 and her MRCP in London in 1998. She has worked extensively in the field of oncology and has a special interest in the hormonal management of breast cancer. She now works with Dr Gudgeon at Cape Breast Care. Read more.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules